Steward Partners Investment Advisory LLC Sells 11,746 Shares of UnitedHealth Group Inc (NYSE:UNH)

Steward Partners Investment Advisory LLC cut its holdings in shares of UnitedHealth Group Inc (NYSE:UNH) by 9.5% during the second quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 111,612 shares of the healthcare conglomerate’s stock after selling 11,746 shares during the period. UnitedHealth Group comprises approximately 1.0% of Steward Partners Investment Advisory LLC’s holdings, making the stock its 15th largest holding. Steward Partners Investment Advisory LLC’s holdings in UnitedHealth Group were worth $27,234,000 at the end of the most recent quarter.

A number of other hedge funds and other institutional investors have also added to or reduced their stakes in UNH. Norges Bank bought a new position in UnitedHealth Group in the 4th quarter valued at $2,343,175,000. Thoroughbred Financial Services LLC boosted its position in UnitedHealth Group by 25,321.4% in the 2nd quarter. Thoroughbred Financial Services LLC now owns 1,922,872 shares of the healthcare conglomerate’s stock valued at $192,287,000 after buying an additional 1,915,308 shares during the last quarter. Sanders Capital LLC boosted its position in UnitedHealth Group by 50.2% in the 2nd quarter. Sanders Capital LLC now owns 4,626,666 shares of the healthcare conglomerate’s stock valued at $1,255,689,000 after buying an additional 1,546,140 shares during the last quarter. FMR LLC boosted its position in UnitedHealth Group by 1.9% in the 4th quarter. FMR LLC now owns 64,480,003 shares of the healthcare conglomerate’s stock valued at $16,063,258,000 after buying an additional 1,232,189 shares during the last quarter. Finally, Geode Capital Management LLC boosted its position in UnitedHealth Group by 9.1% in the 4th quarter. Geode Capital Management LLC now owns 11,593,401 shares of the healthcare conglomerate’s stock valued at $2,882,988,000 after buying an additional 965,763 shares during the last quarter. Institutional investors and hedge funds own 85.87% of the company’s stock.

In other UnitedHealth Group news, Director Richard T. Burke sold 10,000 shares of UnitedHealth Group stock in a transaction dated Tuesday, June 11th. The stock was sold at an average price of $248.00, for a total value of $2,480,000.00. Following the sale, the director now owns 187,663 shares of the company’s stock, valued at approximately $46,540,424. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. Also, Director William C. Ballard, Jr. sold 12,000 shares of UnitedHealth Group stock in a transaction dated Tuesday, July 23rd. The shares were sold at an average price of $255.31, for a total value of $3,063,720.00. Following the completion of the sale, the director now directly owns 61,309 shares in the company, valued at approximately $15,652,800.79. The disclosure for this sale can be found here. Insiders have sold a total of 32,000 shares of company stock worth $7,963,620 in the last ninety days. 0.82% of the stock is currently owned by company insiders.

Several research analysts have recently issued reports on the company. Bank of America restated a “buy” rating and issued a $290.00 price target (down from $320.00) on shares of UnitedHealth Group in a research report on Wednesday, April 17th. Barclays reduced their price target on UnitedHealth Group from $290.00 to $270.00 and set an “overweight” rating on the stock in a research report on Wednesday, April 17th. Oppenheimer set a $312.00 price target on UnitedHealth Group and gave the stock a “buy” rating in a research report on Friday, July 19th. Cantor Fitzgerald set a $310.00 price target on UnitedHealth Group and gave the stock a “buy” rating in a research report on Friday, July 19th. Finally, Raymond James raised their price target on UnitedHealth Group from $265.00 to $300.00 and gave the stock a “buy” rating in a research report on Friday, July 19th. One research analyst has rated the stock with a sell rating, one has given a hold rating and eighteen have given a buy rating to the stock. The stock currently has a consensus rating of “Buy” and a consensus target price of $295.06.

UnitedHealth Group stock traded up $0.19 during mid-day trading on Tuesday, hitting $245.25. 1,461,631 shares of the company’s stock were exchanged, compared to its average volume of 3,766,270. The firm has a market capitalization of $237.63 billion, a price-to-earnings ratio of 19.04, a P/E/G ratio of 1.33 and a beta of 0.61. UnitedHealth Group Inc has a fifty-two week low of $208.07 and a fifty-two week high of $287.94. The company has a quick ratio of 0.73, a current ratio of 0.67 and a debt-to-equity ratio of 0.62. The company has a 50 day moving average price of $251.75.

UnitedHealth Group (NYSE:UNH) last issued its quarterly earnings data on Thursday, July 18th. The healthcare conglomerate reported $3.60 EPS for the quarter, topping the Thomson Reuters’ consensus estimate of $3.46 by $0.14. The business had revenue of $60.60 billion for the quarter, compared to the consensus estimate of $60.59 billion. UnitedHealth Group had a return on equity of 25.20% and a net margin of 5.51%. The firm’s revenue was up 8.0% compared to the same quarter last year. During the same quarter last year, the business posted $3.14 EPS. On average, sell-side analysts anticipate that UnitedHealth Group Inc will post 14.82 earnings per share for the current fiscal year.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. It operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight, and OptumRx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health and well-being services to individuals age 50 and older, addressing their needs for preventive and acute health care services, as well as services dealing with chronic disease and other specialized issues for older individuals; and Medicaid plans, Children's Health Insurance Program, and health care programs; and health and dental benefits.

Further Reading: How to invest in blue-chip stocks

Institutional Ownership by Quarter for UnitedHealth Group (NYSE:UNH)

Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.